Hasegawa T, Nadai M, Wang L, Haghgoo S, Nabeshima T, Kato N
Department of Hospital Pharmacy, Nagoya University School of Medicine, Japan.
Biol Pharm Bull. 1994 Dec;17(12):1651-5. doi: 10.1248/bpb.17.1651.
The contribution of lipid A, an active component of endotoxin (LPS), to changes in the pharmacokinetics, renal handling and intrarenal accumulation of gentamicin induced by Klebsiella pneumoniae LPS was investigated in rats. Either LPS (250 micrograms/kg) or lipid A (equivalent to dose of LPS) was infused 2 h before the administration of gentamicin (10 mg/kg). The effects of LPS and lipid A on the intrarenal accumulation of gentamicin were also evaluated. Significant increases in the levels of plasma creatinine and blood urea nitrogen were observed in both the LPS and lipid A groups. Both LPS and lipid A induced significant decreases in the glomerular filtration rate (by approximately 30%) and systemic clearance of gentamicin (by approximately 25%). No changes in the fraction of urinary excretion (> 0.9) or steady-state volume of distribution of gentamicin were observed between either the control, LPS or lipid A groups. There were no significant differences among the three groups in the tubular reabsorption or intrarenal accumulation of gentamicin. The degree of effect of lipid A on the pharmacokinetics of gentamicin observed in this study was nearly equal to that of LPS. These results suggest that lipid A plays a major role in changes in the pharmacokinetics and renal handling of gentamicin induced by LPS.
在大鼠中研究了内毒素(LPS)的活性成分脂多糖A对肺炎克雷伯菌LPS诱导的庆大霉素药代动力学、肾脏处理及肾内蓄积变化的影响。在给予庆大霉素(10mg/kg)前2小时,输注LPS(250μg/kg)或脂多糖A(相当于LPS的剂量)。还评估了LPS和脂多糖A对庆大霉素肾内蓄积的影响。在LPS组和脂多糖A组均观察到血浆肌酐和血尿素氮水平显著升高。LPS和脂多糖A均导致肾小球滤过率显著降低(约30%)以及庆大霉素的全身清除率显著降低(约25%)。在对照组、LPS组或脂多糖A组之间,未观察到庆大霉素尿排泄分数(>0.9)或稳态分布容积的变化。三组在庆大霉素的肾小管重吸收或肾内蓄积方面无显著差异。本研究中观察到的脂多糖A对庆大霉素药代动力学的影响程度与LPS几乎相等。这些结果表明,脂多糖A在LPS诱导的庆大霉素药代动力学和肾脏处理变化中起主要作用。